Ranked by reported Q2 2026 13F market value
Share of total reported institutional value in KNSA held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | FMR LLC | 7.0M | $445.8M | +2.2% | 9.148% | 0.02% |
| 2 | Rubric Capital Management LP | 4.0M | $255.8M | +6.7% | 5.249% | 2.35% |
| 3 | BAKER BROS. ADVISORS LP | 2.8M | $181.3M | +0.3% | 3.720% | 0.91% |
| 4 | BlackRock, Inc. | 2.7M | $175.2M | +462.8% | 3.595% | 0.00% |
| 5 | TANG CAPITAL MANAGEMENT LLC | 2.3M | $144.5M | 0.0% | 2.966% | 6.56% |
| 6 | VANGUARD PORTFOLIO MANAGEMENT LLC | 1.9M | $122.2M | +8.2% | 2.508% | 0.01% |
| 7 | VANGUARD CAPITAL MANAGEMENT LLC | 1.4M | $87.0M | +2.1% | 1.786% | 0.00% |
| 8 | MORGAN STANLEY | 1.0M | $64.7M | +1.3% | 1.327% | 0.00% |
| 9 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 958K | $61.2M | +7.3% | 1.256% | 0.03% |
| 10 | Spruce Street Capital LP | 918K | $58.7M | +20.6% | 1.205% | 11.52% |
| 11 | DIMENSIONAL FUND ADVISORS LP | 875K | $55.9M | +7.7% | 1.148% | 0.01% |
| 12 | Invesco Ltd. | 773K | $49.4M | +2694.3% | 1.014% | 0.00% |
| 13 | DRIEHAUS CAPITAL MANAGEMENT LLC | 718K | $45.9M | +17.5% | 0.942% | 0.27% |
| 14 | STATE STREET CORP | 704K | $45.0M | +818.9% | 0.924% | 0.00% |
| 15 | Point72 Asset Management, L.P. | 659K | $42.2M | +2.9% | 0.865% | 0.05% |
| 16 | RICE HALL JAMES & ASSOCIATES, LLC | 625K | $40.0M | +2.7% | 0.820% | 1.95% |
| 17 | Pictet Asset Management Holding SA | 609K | $38.9M | -2.4% | 0.799% | 0.04% |
| 18 | GEODE CAPITAL MANAGEMENT, LLC | 604K | $38.6M | +1263.2% | 0.793% | 0.00% |
| 19 | Jupiter Topco LLC | 586K | $37.5M | — | 0.769% | 0.02% |
| 20 | Connor, Clark & Lunn Investment Management Ltd. | 573K | $36.6M | -11.9% | 0.751% | 0.07% |
| 21 | D. E. Shaw & Co., Inc. | 570K | $36.4M | -40.6% | 0.748% | 0.02% |
| 22 | TWO SIGMA INVESTMENTS, LP | 561K | $35.9M | +33.4% | 0.737% | 0.03% |
| 23 | VICTORY CAPITAL MANAGEMENT INC | 505K | $32.3M | -0.3% | 0.662% | 0.02% |
| 24 | BNP PARIBAS FINANCIAL MARKETS | 437K | $28.0M | -32.5% | 0.574% | 0.01% |
| 25 | MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 431K | $27.6M | -1.5% | 0.566% | 0.01% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in KNSA — a direct measure of their conviction.
Filings activity in KNSA during Q2 2026, grouped by how each filer changed its position.
8 quarters of 13F filings · Δ columns show change vs prior quarter
| Quarter | Inst. Holders | Δ Holders | Ownership % | Δ Ownership | Total 13F Value | Δ Value |
|---|---|---|---|---|---|---|
| Q2 2026 | 265 | +17% | 62.00% | +0.16 pp | $2.93B | +38% |
| Q1 2026 | 226 | +1.8% | 61.84% | 7.10 pp | $2.13B | +23% |
| Q4 2025 | 222 | +12% | 68.94% | +12.88 pp | $1.73B | +13% |
| Q3 2025 | 199 | +7.0% | 56.06% | +1.07 pp | $1.53B | +46% |
| Q2 2025 | 186 | +6.3% | 54.99% | 0.83 pp | $1.05B | +23% |
| Q1 2025 | 175 | +12% | 55.82% | +1.31 pp | $848M | +14% |
| Q4 2024 | 156 | 9.8% | 54.51% | 1.18 pp | $747M | 23% |
| Q3 2024 | 173 | — | 55.69% | — | $967M | — |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.
Institutional ownership and quarterly buying activity across the largest Immunology Biotech peers.
Quick answers to the most common questions about buying KNSA stock.
Based on Q2 2026 13F filings, institutional ownership of Kiniksa Pharmaceuticals International, plc stands at 62.0%, held across 265 reporting institutions.
FMR LLC is the largest reported institutional holder of KNSA, with approximately 6,971,361 shares worth $0.45B as of Q2 2026.
Yes — 2 widely-followed marquee investors appear among the top 25 institutional holders of KNSA, including Point72 Asset Management, L.P., TWO SIGMA INVESTMENTS, LP.
Our composite Smart Money Score for KNSA is 65 out of 100 (Bullish). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
65 institutions opened new positions in KNSA during Q2 2026, while 27 fully exited. 152 added to existing positions and 40 trimmed.
KNSA institutional ownership rose by 0.16 percentage points quarter-over-quarter, with a net change of +39 holders.
The top 10 institutions account for 54.5% of all reported 13F value in KNSA, and the top 25 account for 74.7%.
Across the largest Immunology Biotech peers, institutional ownership levels are: LKFT (49.6%), YARW (1.2%), RKTO (7.9%). See the peer comparison table on this page for net buyer activity by company.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.